Editorial: Bristol-Myers offers right Rx.(Viewpoint)(advertising of Bristol-Myers Squibb Co.)(Editorial)

Advertising Age, June, 2005

The decision by Bristol-Myers Squibb to scrub consumer advertising of new prescription drugs is a welcome, reasoned response to issues surrounding drug marketing and safety. We commend Bristol-Myers for taking a bold leadership step and hope Big Pharma will see the wisdom of this move.

It's unfortunate and unnecessary that drug makers are under attack. These companies develop products to cure diseases and vastly improve and lengthen consumers' lives. That's good. But pharma companies have developed the image of profiteering pill-pushers who play fast and loose with research studies, ad claims and matters of product safety and risk. That's bad.

Bristol-Myers is tackling the marketing issue head on, adopting a moratorium that Advertising Age has...

Read the rest of this article with a Free Trial at HighBeam Research.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works.